Skip to search formSkip to main contentSkip to account menu

Yumex

Known as: Humex, Jumex 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Selegiline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Antibacterial activity of fresh pomegranate juice against clinical strains of Staphylococcus epidermidis
Background Polyphenols have received a great deal of attention due to their biological functions. Pomegranate (Punica granatum L… 
2014
2014
Art as Dissent in the Midst of Mexico's Drug War
Review
1997
Review
1997
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
(-)Deprenyl (Selegiline, Jumex, Eldepryl, Movergan), a close structural relative of phenylethylamine (PEA), is a drug with a… 
Review
1995
Review
1995
Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes.
  • J. Knoll
  • Biomedicine & pharmacotherapy = Biomedecine…
  • 1995
  • Corpus ID: 23937858
Review
1993
Review
1993
The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
(-)Deprenyl (Selegiline, Jumex, Eldepryl, Movergan), structurally closely related to phenylethylamine (PEA), is a drug with a… 
1993
1993
[ Selegiline (Jumex) in the treatment of narcolepsy].
Review
1992
Review
1992
Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseases
  • J. Knoll
  • Medicinal research reviews (Print)
  • 1992
  • Corpus ID: 22090168
(-)Deprenyl (Selegiline, Jumex, Eldepryl, Movergan), a close structural relative to phenylethylamine (PEA), is a drug of a unique… 
1987
1987
Brief Information on an Early Phase-ll-Study with Deprenyl in Demented Patients
Eleven elderly female patients (73-88 yrs) suffering from senile dementia of Alzheimer type (7 cases) and from multi-infarct… 
Review
1985
Review
1985
The facilitation of dopaminergic activity in the aged brain by (−)deprenyl. A proposal for a strategy to improve the quality of life in senescence
1982
1982
Clinicopharmacological study of long-term Jumex + Dopaflex combination treatment in Parkinson's syndrome.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)